A Phase 1, Randomized, Observer-blind, Placebo-controlled, Age De-escalation Study of the Safety, Tolerability, and Immunogenicity of mRNA-1345 and mRNA-1365 in Participants Aged 5 months to < 24 mont
Clinical Trial Grant
Awarded By
Moderna Therapeutics, Inc.
Start Date
April 24, 2023
End Date
April 30, 2026
Awarded By
Moderna Therapeutics, Inc.
Start Date
April 24, 2023
End Date
April 30, 2026